BioVentrix Inc. believes its Revivent TC transcatheter ventricular enhancement system represents a breakthrough in technology for reshaping the left ventricle of a failing heart and is supporting multiple clinical trials to prove that.
Revivent TC is intended for patients with symptomatic heart failure and left-ventricular dilatation caused by myocardial scaring after a myocardial...